0005

COM:SAMIL-PHARM

삼일제약

  • Stock

Last Close

14,960.00

12/11 06:30

Market Cap

169.82B

Beta: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
89.23B
-
85.46B
4.22%
88.14B
3.13%
96.76B
9.78%
92.04B
4.88%
94.60B
2.78%
121.11B
28.02%
123.00B
1.56%
134.25B
9.14%
179.68B
33.84%
196.35B
9.28%
cost of revenue
53.09B
-
51.49B
3.03%
50.79B
1.35%
55.31B
8.90%
51.13B
7.55%
59.81B
16.97%
74.38B
24.37%
73.97B
0.56%
85.26B
15.27%
112.19B
31.59%
124.13B
10.65%
gross profit
36.13B
-
33.97B
5.98%
37.35B
9.93%
41.45B
10.98%
40.91B
1.31%
34.79B
14.95%
46.72B
34.30%
49.03B
4.94%
48.99B
0.09%
67.49B
37.76%
72.21B
7.00%
selling and marketing expenses
14.23B
-
15.77B
10.79%
12.03B
23.68%
12.84B
6.69%
13.84B
7.81%
10.15B
26.68%
9.25B
8.87%
10.02B
8.38%
12.18B
21.50%
18.79B
54.30%
16.61B
11.62%
general and administrative expenses
3.47B
-
3.67B
5.56%
4.32B
17.88%
4.57B
5.83%
4.66B
1.99%
8.73B
87.27%
7.71B
11.73%
6.07B
21.27%
7.55B
24.43%
10.38B
37.46%
14.69B
41.49%
selling general and administrative expenses
17.70B
-
19.43B
9.77%
16.35B
15.84%
17.41B
6.46%
18.51B
6.28%
18.88B
2.04%
16.96B
10.20%
16.09B
5.10%
19.73B
22.60%
29.18B
47.86%
59.96B
105.52%
research and development expenses
2.05B
-
2.79B
36.38%
1.12B
59.89%
1.25B
12.10%
1.96B
56.33%
2.18B
11.25%
3.06B
40.25%
3.01B
1.71%
2.97B
1.19%
2.91B
2.17%
5.27B
81.40%
other expenses
-939.97M
-
-1.23B
30.97%
-106.61M
91.34%
-418.90M
292.95%
-11.29M
97.30%
19.46B
172,362.43%
21.88B
12.47%
23.39B
6.90%
25.88B
10.66%
31.39B
21.25%
-516.12M
101.64%
cost and expenses
91.21B
-
94.08B
3.15%
86.53B
8.02%
92.90B
7.36%
90.73B
2.34%
100.33B
10.58%
116.28B
15.90%
116.46B
0.15%
133.85B
14.93%
175.66B
31.24%
189.89B
8.10%
operating expenses
38.11B
-
42.59B
11.75%
35.75B
16.07%
37.60B
5.18%
39.60B
5.32%
40.52B
2.34%
41.90B
3.40%
42.49B
1.41%
48.59B
14.34%
63.47B
30.63%
65.75B
3.60%
interest expense
1.36B
-
1.38B
1.75%
1.20B
13.12%
1.09B
9.17%
1.77B
62.43%
2.39B
35.25%
3.90B
62.96%
5.51B
41.06%
6.20B
12.66%
4.26B
31.27%
3.54B
16.85%
ebitda
17.44B
-
-5.64B
132.32%
4.88B
186.67%
6.97B
42.62%
4.83B
30.65%
-1.87B
138.77%
9.51B
607.55%
11.15B
17.33%
5.77B
48.30%
9.71B
68.42%
11.83B
21.78%
operating income
-1.98B
-
-8.62B
335.42%
1.60B
118.60%
3.85B
140.47%
1.31B
66.08%
-5.73B
538.54%
4.82B
184.14%
6.54B
35.57%
1.05B
83.87%
4.02B
280.78%
6.46B
60.83%
depreciation and amortization
3.53B
-
3.41B
3.29%
3.04B
10.93%
3.15B
3.52%
3.64B
15.77%
3.86B
5.93%
4.68B
21.39%
4.62B
1.46%
4.71B
2.08%
5.70B
20.89%
5.37B
5.76%
total other income expenses net
14.21B
-
-1.60B
111.27%
-549.09M
65.71%
-1.19B
115.82%
-2.02B
70.34%
-2.40B
19.06%
-3.37B
40.11%
-5.34B
58.60%
-5.82B
8.91%
-2.96B
49.13%
-5.04B
70.25%
income before tax
12.23B
-
-10.22B
183.56%
1.05B
110.31%
2.67B
153.32%
-711.60M
126.67%
-8.14B
1,043.22%
1.46B
117.89%
1.20B
17.69%
-4.76B
497.42%
1.06B
122.22%
1.42B
34.51%
income tax expense
4.30B
-
972.44M
77.37%
464.93M
52.19%
1.78B
283.21%
554.96M
68.85%
427.61M
22.95%
669.35M
56.53%
-142.50M
121.29%
585.31M
510.73%
1.09B
85.61%
-239.76M
122.07%
net income
7.93B
-
-11.19B
241.10%
588.37M
105.26%
886.60M
50.69%
-1.27B
242.86%
-8.56B
576.06%
786.26M
109.18%
1.34B
70.50%
-5.35B
498.84%
-28.29M
99.47%
1.66B
5,980.93%
weighted average shs out
11.87M
-
11.72M
1.23%
11.65M
0.64%
11.60M
0.41%
11.62M
0.16%
11.62M
0.02%
13.43M
15.56%
13.45M
0.13%
13.83M
2.85%
13.91M
0.62%
14.32M
2.93%
weighted average shs out dil
11.87M
-
11.72M
1.23%
11.65M
0.64%
11.60M
0.41%
11.63M
0.23%
11.62M
0.05%
13.43M
15.56%
13.45M
0.13%
13.83M
2.85%
13.91M
0.62%
14.42M
3.62%
eps
668.09
-
-954.48
242.87%
50.51
105.29%
76.43
51.32%
-108.93
242.52%
-736.85
576.44%
58.55
107.95%
99.70
70.28%
-386.63
487.79%
-2.03
99.47%
116.16
5,822.17%
epsdiluted
668.09
-
-954.48
242.87%
50.51
105.29%
76.43
51.32%
-108.93
242.52%
-736.82
576.42%
58.55
107.95%
99.70
70.28%
-386.63
487.79%
-2.03
99.47%
115.37
5,783.25%

All numbers in (except ratios and percentages)